{"disease":{"id":"hiv-associated-lipodystrophy-syndrome","name":"hiv associated lipodystrophy syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04887675","title":"Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"University of Novi Sad","has_results":false},{"nct_id":"NCT04340388","title":"Contribution of Dolutegravir to Obesity and Cardiovascular Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Augusta University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}